ArticlePloS one2025
Organization of A3-coupling compounds by magnetic nanocomposite bimetallic in green conditions.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The current project reports two chemical reactions of A3 coupling and creation of three reactans simultaneously and in domino form by bimetallic magnetic nanocatalyst (cobalt/manganese). This bimetallic nanocatalyst was heterogeneously synthesized by a simple chemical co-precipitation method and identified and analyzed by FE-SEM, TEM, VSM, ICP, BET, FT-IR, EDX, etc. analyses. The experimental results showed that the structure of the nanocatalyst is very regular and flexible, and its surface has spaces in nanometer sizes to carry out these chemical reactions. The efficiency and power of the nanocatalyst is very high and it has a special feature for easy separation from the reaction by an external field. The performed triple coupling reactions include the formation of the imide product, the propargylic product. The derivatives of this product each have a high percentage of 76% and selectivity of 98%. These products are widely used in new precursors for making antioxidant and antimicrobial drugs in medical and chemical industries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.